The prolactin secretory response to β-endorphin and the involvement of opiate receptor subtypes in this response was determined in both diestrous and postpartum, lactating female rats. The involvement of the µ-, δ- and/or ĸ-site was determined by administering specific antagonists for each of these sites prior to β-endorphin. β-Funaltrexamine (β-FNA, 1 or 5 µg) was administered to block µ-sites, ICI 154,129 (5,10 or 25 µg) blocked δ-sites and nor-binaltor-phimine (norBNI, 8 µg) blocked ĸ-sites. The ability of β-FNA and ICI 154, 129 to block prolactin secretion following morphine administration was also determined. A dose response study for β-endorphin indicated that β-endorphin, at doses as low as 25 ng, was a potent stimulus for prolactin release producing an increase in prolactin that mimicked the suckling-induced prolactin increase. In addition, all three antagonists were capable of antagonizing the stimulatory effect of β-endorphin in both diestrous and postpartum female rats. These results indicate that β-endorphin is a potent stimulus for prolactin secretion and that these three opiate receptor subtypes interact to produce its stimulatory effect on prolactin release.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.